arrow
M

Michael Krämer

avencell europe gmbh dresden, dresden, germany
H指数:45
被引数:7,378

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial

低甲基化治疗联合或不联合艾曲波帕治疗老年急性髓系白血病患者:来自随机、安慰剂对照的II期DELTA试验结果

2025-10-020
OAAI
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR

异基因造血细胞移植前多色流式细胞术可测量残留病灶检测的预后价值:HLA-DR的潜在作用

2025-08-200
OAAI
Prognostic impact of CEBPA mutational subgroups in adult AML
LEUKEMIA
IF13.4
2024-01-165
OAAI
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
2023-08-042
OA
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3-ITD mutations: results of the SAL MIDOKIT trial
2023-02-093
OAAI
Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies
2022-11-013
OAAI
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia
2022-11-0143
OAAI
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease

异基因造血细胞移植后间充质基质细胞的扰动易患骨髓移植物抗宿主病

2022-10-122
OAAI
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

IDH1和IDH2突变亚群对异基因造血干细胞移植后AML患者的影响

2022-09-0511
OAAI
A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries
2022-07-117
OAAI
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning
2022-06-1616
OAAI
Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD
2022-03-214
OAAI
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study
2022-02-2522
OAAI
Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears
2022-02-2235
OAAI